Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_assertion description "[SEMG-1 is expressed in nearly half of patients with early CLL and may be a target for further investigations into its use for immunotherapy of early CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_assertion evidence source_evidence_literature NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_assertion SIO_000772 19241194 NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_assertion wasDerivedFrom befree-2016 NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_assertion wasGeneratedBy ECO_0000203 NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.
- befree-2016 importedOn "2016-02-19" NP722384.RAyLupX4XSXCL7S8sV1CiyWmeq5aqXPSpcCEgfdkZAxew130_provenance.